Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
Susan L. Whiteway(Uniformed Services University of the Health Sciences), Lisa M. Kopp(University of Arizona), Viswatej Avutu(Memorial Sloan Kettering Cancer Center), Safia K. Ahmed(Mayo Clinic Hospital), Wendy Allen‐Rhoades(Mayo Clinic), Kenneth Cardona(Emory University), Michael S. Isakoff(Center for Cancer and Blood Disorders), Damon R. Reed(Memorial Sloan Kettering Cancer Center), Shreyaskumar Patel(The University of Texas MD Anderson Cancer Center), Katherine A. Janeway(Harvard University), Daniel J. Indelicato(University of Florida), Elizabeth J. Davis(Vanderbilt University Medical Center), Richard F. Riedel(Heidelberg University), Lara E. Davis(Oregon Health & Science University), J. Andrew Livingston(The University of Texas MD Anderson Cancer Center), Katherine A. Thornton(Memorial Sloan Kettering Cancer Center), Aaron R. Weiss(MaineHealth)
Cited by 2
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
|The Lancet|2016|766
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724